NVP-TAE684 reverses multidrug resistance (MDR) in human osteosarcoma by inhibiting P-glycoprotein (PGP1) function-Reference-Cited by-同舟云学术

NVP-TAE684 reverses multidrug resistance (MDR) in human osteosarcoma by inhibiting P-glycoprotein (PGP1) function

Published:2016-01-15 Issue:3 Volume:173 Page:613-626
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:British Journal of Pharmacology

Author:

Ye Shunan¹,Zhang Jianming²,Shen Jacson¹,Gao Yan¹,Li Ying²,Choy Edwin¹,Cote Gregory¹,Harmon David¹,Mankin Henry¹,Gray Nathanael S³,Hornicek Francis J¹,Duan Zhenfeng¹

Affiliation:

1. Center for Sarcoma and Connective Tissue Oncology, Massachusetts General Hospital; Harvard Medical School; Boston MA USA

2. Cutaneous Biology Research Center, Massachusetts General Hospital; Harvard Medical School; Boston MA USA

3. Dana Farber Cancer Institute; Harvard Medical School; Boston MA USA

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bph.13395/fullpdf

Reference52 articles.

1. Ovarian cancer: strategies for overcoming resistance to chemotherapy;Agarwal;Nat Rev Cancer,2003

2. Flavonoid structure-activity studies identify 6-prenylchrysin and tectochrysin as potent and specific inhibitors of breast cancer resistance protein ABCG2;Ahmed-Belkacem;Cancer Res,2005

3. The Concise Guide to PHARMACOLOGY 2015/16: Catalytic receptors;Alexander;Br J Pharmacol,2015a

4. The Concise Guide to PHARMACOLOGY 2015/16: Enzymes;Alexander;Br J Pharmacol,2015b

5. The Concise Guide to PHARMACOLOGY 2015/16: Transporters;Alexander;Br J Pharmacol,2015c

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of miRNA signature in cancer-associated fibroblast to predict recurrent prostate cancer;Computers in Biology and Medicine;2024-09

2. Stratification of ovarian cancer patients from the prospect of drug target-related transcription factor protein activity: the prognostic and genomic landscape analyses;Briefings in Functional Genomics;2023-04-10

3. Prediction of drug candidates for clear cell renal cell carcinoma using a systems biology-based drug repositioning approach;eBioMedicine;2022-04

4. Anlotinib Reverses Multidrug Resistance (MDR) in Osteosarcoma by Inhibiting P-Glycoprotein (PGP1) Function In Vitro and In Vivo;Frontiers in Pharmacology;2022-01-17

5. Novel Pt(IV) complexes to overcome multidrug resistance in gastric cancer by targeting P-glycoprotein;European Journal of Medicinal Chemistry;2021-10